What Does PLIER Really Do?

Por Therneau, Terry M., Ballman, Karla V.
Publicado em 2008

Taking the long view: how to design a series of Phase III trials to maximize cumulative therapeutic benefit

Por Le Deley, Marie-Cécile, Ballman, Karla V, Marandet, Julien, Sargent, Daniel
Publicado em 2012

Impact of imaging measurements on response assessment in glioblastoma clinical trials

Por Reardon, David A., Ballman, Karla V., Buckner, Jan C., Chang, Susan M., Ellingson, Benjamin M.
Publicado em 2014

Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial

Por Advani, Pooja P., Ballman, Karla V., Dockter, Travis J., Colon-Otero, Gerardo, Perez, Edith A.
Publicado no J Clin Oncol (2016)

Effects of the 5 Alpha-Reductase Inhibitor Dutasteride on Gene Expression in Prostate Cancer Xenografts

Por Schmidt, Lucy J., Regan, Kevin M., Anderson, S. Keith, Sun, Zhifu, Ballman, Karla V., Tindall, Donald J.
Publicado em 2009

Guidelines for Statistical Reporting in Medical Journals

Por Ou, Fang-Shu, Le-Rademacher, Jennifer G., Ballman, Karla V., Adjei, Alex A., Mandrekar, Sumithra J.
Publicado no J Thorac Oncol (2020)

Androgen Modulation of Coregulator Expression in Prostate Cancer Cells

Por Heemers, Hannelore V., Regan, Kevin M., Schmidt, Lucy J., Anderson, S. Keith, Ballman, Karla V., Tindall, Donald J.
Publicado em 2009

Effect of Body Mass Index (BMI) on Tumor Characteristics and Disease-Free Survival in Patients from the HER2-Positive Adjuvant Trastuzumab Trial N9831

Por Crozier, Jennifer A., Moreno-Aspitia, Alvaro, Ballman, Karla V., Dueck, Amylou C., Pockaj, Barbara A., Perez, Edith A.
Publicado em 2013

Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer

Por Perez, Edith A., Ballman, Karla V., Tenner, Kathy S., Thompson, E. Aubrey, Badve, Sunil S., Bailey, Helen, Baehner, Frederick L.
Publicado no JAMA Oncol (2016)

Impact of radiation on local regional control in women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary lymph node dissection: Results from ACOSO...

Por Haffty, Bruce G., McCall, Linda M., Ballman, Karla V., Buchholz, Thomas A., Hunt, Kelly K., Boughey, Judy C.
Publicado no Int J Radiat Oncol Biol Phys (2019)

Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion

Por Toussaint L, Nilson Allan E, Goble Jennie M, Ballman Karla V, James C, Lefranc Florence, Kiss Robert, Uhm Joon H
Publicado em 2012-05-01

Association Studies of Fcγ Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831

Por Norton, Nadine, Olson, Rebecca M., Pegram, Mark, Tenner, Kathleen, Ballman, Karla V., Clynes, Raphael, Knutson, Keith L., Perez, Edith A.
Publicado em 2014

Impact of Race, Ethnicity and BMI on Achievement of Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer: A Pooled Analysis of Four Prospective Allianc...

Por Warner, Erica T., Ballman, Karla V., Strand, Carrie, Boughey, Judy, Buzdar, Aman U., Carey, Lisa A., Sikov, William M., Partridge, H.
Publicado no Breast Cancer Res Treat (2016)

The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme

Por Ballman, Karla V., Buckner, Jan C., Brown, Paul D., Giannini, Caterina, Flynn, Patrick J., LaPlant, Betsy R., Jaeckle, Kurt A.
Publicado em 2007

Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion

Por Toussaint, L Gerard, Nilson, Allan E, Goble, Jennie M, Ballman, Karla V, James, C David, Lefranc, Florence, Kiss, Robert, Uhm, Joon H
Publicado em 2012

Utility of Digital Rectal Examination (DRE) as an Adjunct to Prostate Specific Antigen (PSA) in the Detection of Clinically Significant Prostate Cancer

Por Halpern, Joshua A., Oromendia, Clara, Shoag, Jonathan E., Mittal, Sameer, Cosiano, Michael F., Ballman, Karla V., Vickers, Andrew J., Hu, Jim C.
Publicado no J Urol (2017)

Validation of neuroradiologic response assessment in gliomas: Measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods

Por Galanis, Evanthia, Buckner, Jan C., Maurer, Matthew J., Sykora, Rene, Castillo, René, Ballman, Karla V., Erickson for the North Central Cancer Treatment Group, Bradley J.
Publicado em 2006

Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection

Por Armer, Jane M., Ballman, Karla V., McCall, Linda, Ostby, Pamela L., Zagar, Eris, Kuerer, Henry M., Hunt, Kelly K., Boughey, Judy C.
Publicado no JAMA Surg (2019)

P-glycoprotein-mediated resistance to HSP90-directed therapy is eclipsed by the heat shock response

Por McCollum, Andrea K., TenEyck, Cynthia J., Stensgard, Bridget, Morlan, Bruce W., Ballman, Karla V., Jenkins, Robert B., Toft, David O., Erlichman, Charles
Publicado em 2008

Tumor Biology and Response to Chemotherapy Impact Breast Cancer-Specific Survival in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Long-term Follow-up...

Por Boughey, Judy C., Ballman, Karla V., McCall, Linda M., Mittendorf, Elizabeth A., Symmans, W. Fraser, Julian, Thomas B., Byrd, David, Hunt, Kelly K.
Publicado no Ann Surg (2017)